每周股票复盘：东诚药业（002675）2024年度权益分派实施

Summary of Key Points Core Viewpoint - Dongcheng Pharmaceutical (002675) has announced a cash dividend distribution plan for the year 2024, which is expected to enhance shareholder value and reflects the company's ongoing commitment to returning profits to its investors [1][2]. Company Announcement Summary - The company will distribute a cash dividend of RMB 0.30 per 10 shares, totaling RMB 24,737,871.15, based on a total share capital of 824,595,705 shares as of December 31, 2024 [2]. - After the profit distribution, the remaining undistributed profits amount to RMB 1,338,768,971.39, which will be carried forward to the next fiscal year [2]. - The dividend distribution plan has been approved by the company's 2024 annual general meeting and will be executed without any changes to the total share capital [2]. - Key dates include the equity registration date on May 26, 2025, and the ex-dividend date on May 27, 2025 [2]. - Cash dividends for A-share shareholders will be directly credited to their accounts through their securities companies on the ex-dividend date [2].